.Along with a triad of biotechs reaching the Nasdaq on Friday, it was actually quick and easy to ski...
.Invulnerable checkpoint preventions are the superheroes of cancer therapy. Medications like Bristol...
.Welcome to this week's Chutes & Ladders, our roundup of considerable leadership hirings, firings...
.Regeneron is actually back along with lasting consequence for its own LAG-3 inhibitor and PD-1 inhi...
.AstraZeneca has actually shared a very early examine the performance of its own in-house antibody-d...
.After revealing a phase 3 launch based on favorable midstage outcomes, iTeos and GSK are ultimately...
.The FDA must be actually much more available and joint to discharge a surge in approvals of uncommo...
.It's an abnormally active Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bicar...
.Atea Pharmaceuticals' antiviral has actually fallen short another COVID-19 trial, however the biote...
.Neurocrine Biosciences' schizophrenia plan pivot has actually stopped working. The biotech was actu...